The drug-drug interaction between proton pump inhibitors and clopidogrel.
作者信息
Lau Wei C, Gurbel Paul A
机构信息
4172 Cardiovascular Center, University of Michigan Health System, 1500 E Medical Center Drive, Ann Arbor, MI 48109-5861, USA.
出版信息
CMAJ. 2009 Mar 31;180(7):699-700. doi: 10.1503/cmaj.090251.
Abstract
摘要
相似文献
1
The drug-drug interaction between proton pump inhibitors and clopidogrel.质子泵抑制剂与氯吡格雷之间的药物相互作用。
CMAJ. 2009 Mar 31;180(7):699-700. doi: 10.1503/cmaj.090251.
2
Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data?质子泵抑制剂与氯吡格雷——危险的药物相互作用还是对数据的危险解读？
Can J Gastroenterol. 2009 Apr;23(4):251-2. doi: 10.1155/2009/868946.
3
[Clopidogrel plus proton pump inhibitor: is infarct risk increased? (interview by Dr. Thomas Meissner)].
MMW Fortschr Med. 2009 Jun 4;151(23):7.
4
No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.质子泵抑制剂与氯吡格雷联用时心血管风险无显著差异的一致性证据：荟萃分析。
Int J Cardiol. 2013 Aug 10;167(3):965-74. doi: 10.1016/j.ijcard.2012.03.085. Epub 2012 Mar 30.
5
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.一项基于人群的质子泵抑制剂与氯吡格雷药物相互作用的研究。
CMAJ. 2009 Mar 31;180(7):713-8. doi: 10.1503/cmaj.082001. Epub 2009 Jan 28.
6
Safety of concomitant use of proton pump inhibitors and clopidogrel.
Am J Med. 2010 Apr;123(4):e11; author reply e13. doi: 10.1016/j.amjmed.2009.10.010.
7
Conflicting evidence surrounding the clopidogrel and proton pump inhibitor drug interaction.关于氯吡格雷与质子泵抑制剂药物相互作用的证据相互矛盾。
Arch Intern Med. 2010 Sep 13;170(16):1507-8; author reply 1508. doi: 10.1001/archinternmed.2010.299.
8
The prevalence of co-administration of clopidogrel and proton pump inhibitors.氯吡格雷与质子泵抑制剂联合使用的发生率。
Qual Prim Care. 2011;19(1):35-42.
9
Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel.荟萃分析：质子泵抑制剂对接受氯吡格雷治疗的患者心血管事件和死亡率的影响。
Aliment Pharmacol Ther. 2010 Apr;31(8):810-23. doi: 10.1111/j.1365-2036.2010.04247.x. Epub 2010 Jan 22.
10
[Proton pump inhibitors and clopidogrel: a hazardous association?].
Rev Med Interne. 2013 Feb;34(2):99-104. doi: 10.1016/j.revmed.2012.11.001. Epub 2012 Nov 29.
引用本文的文献
1
Rabeprazole Coadministration Controls Ulcer Recurrence in Patients on Low-dose Aspirin Therapy: A Multicenter Prospective Study.雷贝拉唑辅助治疗低剂量阿司匹林治疗患者的溃疡复发：一项多中心前瞻性研究。
Intern Med. 2023 Feb 15;62(4):495-502. doi: 10.2169/internalmedicine.9646-22. Epub 2022 Jul 29.
2
Association of KDR rs1870377 genotype with clopidogrel resistance in patients with post percutaneous coronary intervention.经皮冠状动脉介入治疗术后患者中KDR基因rs1870377基因型与氯吡格雷抵抗的相关性
Heliyon. 2021 Feb 16;7(2):e06251. doi: 10.1016/j.heliyon.2021.e06251. eCollection 2021 Feb.
3
Patterns and characteristics of polypharmacy among elderly residents in Danish nursing homes.丹麦养老院老年居民多重用药的模式与特征。
Future Sci OA. 2020 May 29;6(8):FSO590. doi: 10.2144/fsoa-2020-0039.
4
Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice.细胞色素P450酶抑制机制：理解临床实践中基于机制的抑制所导致的药物相互作用。
Pharmaceutics. 2020 Sep 4;12(9):846. doi: 10.3390/pharmaceutics12090846.
5
Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study.Vonoprazan 预防低剂量阿司匹林相关溃疡复发：随机 3 期研究。
Gut. 2018 Jun;67(6):1033-1041. doi: 10.1136/gutjnl-2017-314852. Epub 2017 Dec 1.
6
A randomized controlled trial of adjunctive Bunchang Naoxintong Capsule (步长脑心通胶囊) versus maintenance dose clopidogrel in patients with CYP2C19*2 polymorphism.一项针对携带CYP2C19*2基因多态性患者的随机对照试验：辅助使用步长脑心通胶囊与维持剂量氯吡格雷的对比研究
Chin J Integr Med. 2014 Dec;20(12):894-902. doi: 10.1007/s11655-014-2023-z. Epub 2014 Nov 27.
7
Drug-drug interactions and their predictors: Results from Indian elderly inpatients.药物相互作用及其预测因素：印度老年住院患者的研究结果
Pharm Pract (Granada). 2013 Oct;11(4):191-5. doi: 10.4321/s1886-36552013000400003. Epub 2013 Dec 20.
8
The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage.H2 拮抗剂在治疗和预防 NSAID 诱导的黏膜损伤中的应用。
Arthritis Res Ther. 2013;15 Suppl 3(Suppl 3):S6. doi: 10.1186/ar4178. Epub 2013 Jul 24.
9
P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?急性冠状动脉综合征中的 P2Y12 受体抑制剂：前景如何？
Cardiol Res Pract. 2013;2013:195456. doi: 10.1155/2013/195456. Epub 2013 Feb 19.
10
In Vitro Assessment of Cytochrome P450 2C19 Potential of Naoxintong.醒脑通的体外细胞色素 P450 2C19 潜在活性评估。
Evid Based Complement Alternat Med. 2012;2012:430262. doi: 10.1155/2012/430262. Epub 2012 Feb 16.
本文引用的文献
1
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.一项基于人群的质子泵抑制剂与氯吡格雷药物相互作用的研究。
CMAJ. 2009 Mar 31;180(7):713-8. doi: 10.1503/cmaj.082001. Epub 2009 Jan 28.
2
Cytochrome p-450 polymorphisms and response to clopidogrel.细胞色素P-450基因多态性与氯吡格雷的反应
N Engl J Med. 2009 Jan 22;360(4):354-62. doi: 10.1056/NEJMoa0809171. Epub 2008 Dec 22.
3
Genetic determinants of response to clopidogrel and cardiovascular events.氯吡格雷反应及心血管事件的遗传决定因素。
N Engl J Med. 2009 Jan 22;360(4):363-75. doi: 10.1056/NEJMoa0808227. Epub 2008 Dec 22.
4
The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance.CYP2C19基因多态性对氯吡格雷药代动力学和药效学的影响：氯吡格雷抵抗的一种可能机制。
Clin Pharmacol Ther. 2008 Aug;84(2):236-42. doi: 10.1038/clpt.2008.20. Epub 2008 Mar 5.
5
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.奥美拉唑对与阿司匹林联用的氯吡格雷抗血小板作用的影响：随机、双盲的OCLA（奥美拉唑-氯吡格雷-阿司匹林）研究
J Am Coll Cardiol. 2008 Jan 22;51(3):256-60. doi: 10.1016/j.jacc.2007.06.064.
6
Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently.酮康唑对细胞色素P450 3A的抑制作用对普拉格雷和氯吡格雷的药代动力学和药效动力学有不同影响。
Clin Pharmacol Ther. 2007 May;81(5):735-41. doi: 10.1038/sj.clpt.6100139. Epub 2007 Mar 14.
7
Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?接受氯吡格雷长期治疗的高血小板聚集患者在接受经皮冠状动脉介入治疗时风险增加：当前的抗血小板治疗是否足够？
J Am Coll Cardiol. 2007 Feb 13;49(6):657-66. doi: 10.1016/j.jacc.2006.10.050. Epub 2007 Jan 26.
8
Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study.氯吡格雷对支架内血栓形成患者血小板反应性的影响：CREST研究结果
J Am Coll Cardiol. 2005 Nov 15;46(10):1827-32. doi: 10.1016/j.jacc.2005.07.056. Epub 2005 Oct 19.
9
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.质子泵抑制药物奥美拉唑、埃索美拉唑、兰索拉唑、泮托拉唑和雷贝拉唑对人细胞色素P450活性的抑制作用比较。
Drug Metab Dispos. 2004 Aug;32(8):821-7. doi: 10.1124/dmd.32.8.821.
10
The influence of St John's Wort on CYP2C19 activity with respect to genotype.圣约翰草对不同基因型CYP2C19活性的影响。
J Clin Pharmacol. 2004 Jun;44(6):577-81. doi: 10.1177/0091270004265642.
Zotero 插件